The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) is holding a very important meeting on May 22, 2025. Under consideration at this meeting is the fate of the Covid booster shots. There has been considerable anticipation as well as media claims that current recommendations and authorization for these products’ use, particularly in children and pregnant women, may be discontinued.
Public comments are currently being solicited for the meeting, and wide public interest surrounds this event. Unfortunately, I have received reports from colleagues that some comments submitted to the committee calling for discontinuation of these vaccines have disappeared from the FDA website.
Furthermore, an important article from the FDA published today in the New England Journal of Medicine acknowledges the huge discrepancies in Covid vaccine recommendations in the US vs. other countries – as I describe in detail below. The article hints yet again at possible changes in official recommendations regarding the Covid vaccines. In terms of actual changes, however, none have yet been made official